These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28351757)

  • 21. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
    Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?
    Humpel C
    Adv Exp Med Biol; 2021; 1331():193-202. PubMed ID: 34453299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
    Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve Growth Factor-Based Therapy in Alzheimer's Disease and Age-Related Macular Degeneration.
    Amadoro G; Latina V; Balzamino BO; Squitti R; Varano M; Calissano P; Micera A
    Front Neurosci; 2021; 15():735928. PubMed ID: 34566573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
    Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
    Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration.
    Yuan X; Jia Z; Li J; Liu Y; Huang Y; Gong Y; Guo X; Chen X; Cen J; Liu J
    J Mater Chem B; 2021 Sep; 9(37):7835-7847. PubMed ID: 34586144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease.
    Vedagiri A; Thangarajan S
    Neuropeptides; 2016 Aug; 58():111-25. PubMed ID: 27021394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.
    Kuo YC; Chou PR
    J Pharm Sci; 2014 Aug; 103(8):2484-97. PubMed ID: 25041794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons.
    Böttger D; Ullrich C; Humpel C
    Brain Res; 2010 Feb; 1312():108-19. PubMed ID: 20004179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: review of current nanotechnological therapeutic strategies.
    Baranowska-Wójcik E; Szwajgier D
    Expert Rev Neurother; 2020 Mar; 20(3):271-279. PubMed ID: 31957510
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.
    Karthivashan G; Ganesan P; Park SY; Kim JS; Choi DK
    Drug Deliv; 2018 Nov; 25(1):307-320. PubMed ID: 29350055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
    Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C
    J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease.
    Zhou H; Gong Y; Liu Y; Huang A; Zhu X; Liu J; Yuan G; Zhang L; Wei JA; Liu J
    Biomaterials; 2020 Apr; 237():119822. PubMed ID: 32035322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease.
    Lauzon MA; Daviau A; Marcos B; Faucheux N
    J Control Release; 2015 May; 206():187-205. PubMed ID: 25804873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.
    Andrieux K; Couvreur P
    Ann Pharm Fr; 2013 Jul; 71(4):225-33. PubMed ID: 23835020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease.
    Rattray M
    Biol Psychiatry; 2001 Feb; 49(3):185-93. PubMed ID: 11230869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
    Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
    Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.